| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.004 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |